In this issue:

• What happens if the US engineers a near monopoly on the supply of COVID-19 medicines and vaccines
• Why are governments encouraging the airline behemoths?
• Has the UK suddenly become the most aggressive of competition authorities
• The EU continues to target big tech
• 80,000 post-COVID complaints to the CMA – 7,000 per day
• Small banks consistently beat big banks on loans
• Twitter vs Trump